ICON plc

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
HZNPHorizon Therapeutics Plc 5.68%58.386.5%$171.51m
CTLTCatalent, Inc. 0.54%73.132.1%$127.43m
JAZZJazz Pharmaceuticals Plc 1.85%111.782.4%$113.54m
VRXValeant Pharmaceuticals International, Inc. 3.87%19.0514.1%$112.09m
BHCBausch Health Cos., Inc. 3.82%19.040.0%$83.95m
UTHRUnited Therapeutics Corp. -0.69%119.5014.3%$72.60m
ICPTIntercept Pharmaceuticals, Inc. 1.23%47.6716.8%$61.83m
AXSMAxsome Therapeutics, Inc. 1.90%82.511.9%$53.73m
ZGNXZogenix, Inc. 1.44%29.617.5%$51.45m
PRGOPerrigo Co. Plc 0.42%55.426.8%$49.30m
MYOKMyoKardia, Inc. -1.78%92.441.8%$46.11m
AMRNAmarin Corp. Plc 1.23%7.011.6%$44.07m
PCRXPacira Biosciences, Inc. 4.95%54.9610.3%$41.98m
ARGXargenx SE 3.18%235.990.0%$41.46m
ICLRICON plc 1.43%169.304.3%$39.12m

Company Profile

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.